Market Study on Macular Degeneration Treatment: North America Enjoys Over Two-fifths Market Share

Oct 2022| PMR2189A| Persistence Market Research

Report Highlights

Macular Degeneration Treatment Market: Scope of Report

The latest publication by Persistence Market Research on the global macular degeneration treatment market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers in knowing the demand for macular degeneration treatment products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the macular degeneration treatment market. Shareholders in the macular degeneration treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the macular degeneration treatment market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the macular degeneration treatment market offers information divided into five important segments – drug, indication, route of administration, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug

  • Anti-vascular Endothelial Growth Factors
  • Other

Route of Administration

  • Intravenous Route
  • Intravitreal Route
  • Others

Indication

  • Dry Age-related Macular Degeneration
  • Wet Age-related Macular Degeneration

End User

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgical Centers
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for macular degeneration treatment over the coming years?
  • How will changing trends influence the market?
  • How has the COVID-19 crisis influenced market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will affect the market?
  • How can companies in the macular degeneration treatment market avail themselves the growth opportunities in developed and emerging sectors?

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2032
Units considered $ Million
Segments covered By Drug, By Route of administration, By Indication, By End User, By Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Companies studied
  • F. Hoffmann-La Roche Ltd.,
  • Samsung Bioepis,
  • Novartis AG,
  • Bayer AG,
  • Pfizer Inc.,
  • Bausch Health Companies Inc.,
  • Regeneron Pharmaceuticals Inc.,
  • Amgen Inc.,
  • Biogen,
  • Santen Pharmaceutical Co., Ltd.

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the macular degeneration treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the macular degeneration treatment market more accurate and reliable.

  • Table 1 : Global Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 2 : Global Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Route of administration
  • Table 3 : Global Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Indication
  • Table 4 : Global Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by End User
  • Table 5 : Global Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Region
  • Table 6 : North America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 7 : North America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 8 : North America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of administration
  • Table 9 : North America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Indication
  • Table 10 : North America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
  • Table 11 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 12 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 13 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of administration
  • Table 14 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Indication
  • Table 15 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
  • Table 16 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 17 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 18 : Europe Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Route of administration
  • Table 19 : Europe Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Indication
  • Table 20 : Europe Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by End User
  • Table 21 : East Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 22 : East Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 23 : East Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of administration
  • Table 24 : East Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Indication
  • Table 25 : East Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
  • Table 26 : South Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 27 : South Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 28 : South Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of administration
  • Table 29 : South Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Indication
  • Table 30 : South Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User
  • Table 31 : Oceania Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 32 : Oceania Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 33 : Oceania Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Route of administration
  • Table 34 : Oceania Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Indication
  • Table 35 : Oceania Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by End User
  • Table 36 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country
  • Table 37 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug
  • Table 38 : Middle East & Africa Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Route of administration
  • Table 39 : Middle East & Africa Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by Indication
  • Table 40 : Middle East & Africa Macular Degeneration Treatment Market Analysis 2012–2021 and Forecast 2022–2032, by End User
  • Figure 1 : Global Macular Degeneration Treatment Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 2 : Global Macular Degeneration Treatment Market Forecast & Y-o-Y Growth, 2022–2032
  • Figure 3 : Global Macular Degeneration Treatment Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032
  • Figure 4 : Global Macular Degeneration Treatment Market Value Share (%) Analysis 2022 and 2032, by Drug
  • Figure 5 : Global Macular Degeneration Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by Drug
  • Figure 6 : Global Macular Degeneration Treatment Market Attractiveness Analysis 2022–2032, by Drug
  • Figure 7 : Global Macular Degeneration Treatment Market Value Share (%) Analysis 2022 and 2032, by Route of administration
  • Figure 8 : Global Macular Degeneration Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by Route of administration
  • Figure 9 : Global Macular Degeneration Treatment Market Attractiveness Analysis 2022–2032, by Route of administration
  • Figure 10 : Global Macular Degeneration Treatment Market Value Share (%) Analysis 2022 and 2032, by Indication
  • Figure 11 : Global Macular Degeneration Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by Indication
  • Figure 12 : Global Macular Degeneration Treatment Market Attractiveness Analysis 2022–2032, by Indication
  • Figure 13 : Global Macular Degeneration Treatment Market Value Share (%) Analysis 2022 and 2032, by End User
  • Figure 14 : Global Macular Degeneration Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by End User
  • Figure 15 : Global Macular Degeneration Treatment Market Attractiveness Analysis 2022–2032, by End User
  • Figure 16 : Global Macular Degeneration Treatment Market Value Share (%) Analysis 2022 and 2032, by Region
  • Figure 17 : Global Macular Degeneration Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by Region
  • Figure 18 : Global Macular Degeneration Treatment Market Attractiveness Analysis 2022–2032, by Region
  • Figure 19 : North America Macular Degeneration Treatment Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 20 : North America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 21 : North America Macular Degeneration Treatment Market Value Share, by Drug (2022 E)
  • Figure 22 : North America Macular Degeneration Treatment Market Value Share, by Route of administration (2022 E)
  • Figure 23 : North America Macular Degeneration Treatment Market Value Share, by Indication (2022 E)
  • Figure 24 : North America Macular Degeneration Treatment Market Value Share, by End User (2022 E)
  • Figure 25 : North America Macular Degeneration Treatment Market Value Share, by Country (2022 E)
  • Figure 26 : North America Macular Degeneration Treatment Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 27 : North America Macular Degeneration Treatment Market Attractiveness Analysis by Route of administration, 2022–2032
  • Figure 28 : North America Macular Degeneration Treatment Market Attractiveness Analysis by Indication, 2022–2032
  • Figure 29 : North America Macular Degeneration Treatment Market Attractiveness Analysis by End User, 2022–2032
  • Figure 30 : North America Macular Degeneration Treatment Market Attractiveness Analysis by Country, 2022–2032
  • Figure 31 : U.S. Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 32 : Global Vs. U.S. Growth Comparison
  • Figure 33 : U.S. Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 34 : U.S. Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 35 : U.S. Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 36 : U.S. Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 37 : Canada Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 38 : Global Vs. Canada. Growth Comparison
  • Figure 39 : Canada Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 40 : Canada Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 41 : Canada Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 42 : Canada Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 43 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 44 : Latin America Macular Degeneration Treatment Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 45 : Latin America Macular Degeneration Treatment Market Value Share, by Drug (2022 E)
  • Figure 46 : Latin America Macular Degeneration Treatment Market Value Share, by Route of administration (2022 E)
  • Figure 47 : Latin America Macular Degeneration Treatment Market Value Share, by Indication (2022 E)
  • Figure 48 : Latin America Macular Degeneration Treatment Market Value Share, by End User (2022 E)
  • Figure 49 : Latin America Macular Degeneration Treatment Market Value Share, by Country (2022 E)
  • Figure 50 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 51 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis by Route of administration, 2022–2032
  • Figure 52 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis by Indication, 2022–2032
  • Figure 53 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis by End User, 2022–2032
  • Figure 54 : Latin America Macular Degeneration Treatment Market Attractiveness Analysis by Country, 2022–2032
  • Figure 55 : Mexico Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 56 : Global Vs Mexico Growth Comparison
  • Figure 57 : Mexico Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 58 : Mexico Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 59 : Mexico Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 60 : Mexico Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 61 : Brazil Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 62 : Global Vs. Brazil. Growth Comparison
  • Figure 63 : Brazil Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 64 : Brazil Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 65 : Brazil Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 66 : Brazil Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 67 : Argentina Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 68 : Global Vs Argentina Growth Comparison
  • Figure 69 : Argentina Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 70 : Argentina Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 71 : Argentina Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 72 : Argentina Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 73 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 74 : Europe Macular Degeneration Treatment Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 75 : Europe Macular Degeneration Treatment Market Value Share, by Drug (2022 E)
  • Figure 76 : Europe Macular Degeneration Treatment Market Value Share, by Route of administration (2022 E)
  • Figure 77 : Europe Macular Degeneration Treatment Market Value Share, by Indication (2022 E)
  • Figure 78 : Europe Macular Degeneration Treatment Market Value Share, by End User (2022 E)
  • Figure 79 : Europe Macular Degeneration Treatment Market Value Share, by Country (2022 E)
  • Figure 80 : Europe Macular Degeneration Treatment Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 81 : Europe Macular Degeneration Treatment Market Attractiveness Analysis by Route of administration, 2022–2032
  • Figure 82 : Europe Macular Degeneration Treatment Market Attractiveness Analysis by Indication, 2022–2032
  • Figure 83 : Europe Macular Degeneration Treatment Market Attractiveness Analysis by End User, 2022–2032
  • Figure 84 : Europe Macular Degeneration Treatment Market Attractiveness Analysis by Country, 2022–2032
  • Figure 85 : UK Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 86 : Global Vs. UK Growth Comparison
  • Figure 87 : UK Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 88 : UK Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 89 : UK Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 90 : UK Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 91 : Germany Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 92 : Global Vs. Germany Growth Comparison
  • Figure 93 : Germany Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 94 : Germany Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 95 : Germany Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 96 : Germany Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 97 : Italy Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 98 : Global Vs. Italy Growth Comparison
  • Figure 99 : Italy Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 100 : Italy Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 101 : Italy Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 102 : Italy Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 103 : France Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 104 : Global Vs France Growth Comparison
  • Figure 105 : France Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 106 : France Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 107 : France Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 108 : France Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 109 : Spain Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 110 : Global Vs Spain Growth Comparison
  • Figure 111 : Spain Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 112 : Spain Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 113 : Spain Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 114 : Spain Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 115 : Russia Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 116 : Global Vs Russia Growth Comparison
  • Figure 117 : Russia Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 118 : Russia Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 119 : Russia Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 120 : Russia Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 121 : BENELUX Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 122 : Global Vs BENELUX Growth Comparison
  • Figure 123 : BENELUX Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 124 : BENELUX Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 125 : BENELUX Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 126 : BENELUX Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 127 : East Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 128 : East Asia Macular Degeneration Treatment Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 129 : East Asia Macular Degeneration Treatment Market Value Share, by Drug (2022 E)
  • Figure 130 : East Asia Macular Degeneration Treatment Market Value Share, by Route of administration (2022 E)
  • Figure 131 : East Asia Macular Degeneration Treatment Market Value Share, by Indication (2022 E)
  • Figure 132 : East Asia Macular Degeneration Treatment Market Value Share, by End User (2022 E)
  • Figure 133 : East Asia Macular Degeneration Treatment Market Value Share, by Country (2022 E)
  • Figure 134 : East Asia Macular Degeneration Treatment Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 135 : East Asia Macular Degeneration Treatment Market Attractiveness Analysis by Route of administration, 2022–2032
  • Figure 136 : East Asia Macular Degeneration Treatment Market Attractiveness Analysis by Indication, 2022–2032
  • Figure 137 : East Asia Macular Degeneration Treatment Market Attractiveness Analysis by End User, 2022–2032
  • Figure 138 : East Asia Macular Degeneration Treatment Market Attractiveness Analysis by Country, 2022–2032
  • Figure 139 : China Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 140 : Global Vs. China Growth Comparison
  • Figure 141 : China Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 142 : China Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 143 : China Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 144 : China Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 145 : Japan Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 146 : Global Vs. Japan Growth Comparison
  • Figure 147 : Japan Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 148 : Japan Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 149 : Japan Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 150 : Japan Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 151 : South Korea Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 152 : Global Vs South Korea Growth Comparison
  • Figure 153 : South Korea Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 154 : South Korea Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 155 : South Korea Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 156 : South Korea Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 157 : South Asia Macular Degeneration Treatment Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 158 : South Asia Macular Degeneration Treatment Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 159 : South Asia Macular Degeneration Treatment Market Value Share, by Drug (2022 E)
  • Figure 160 : South Asia Macular Degeneration Treatment Market Value Share, by Route of administration (2022 E)
  • Figure 161 : South Asia Macular Degeneration Treatment Market Value Share, by Indication (2022 E)
  • Figure 162 : South Asia Macular Degeneration Treatment Market Value Share, by End User (2022 E)
  • Figure 163 : South Asia Macular Degeneration Treatment Market Value Share, by Country (2022 E)
  • Figure 164 : South Asia Macular Degeneration Treatment Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 165 : South Asia Macular Degeneration Treatment Market Attractiveness Analysis by Route of administration, 2022–2032
  • Figure 166 : South Asia Macular Degeneration Treatment Market Attractiveness Analysis by Indication, 2022–2032
  • Figure 167 : South Asia Macular Degeneration Treatment Market Attractiveness Analysis by End User, 2022–2032
  • Figure 168 : South Asia Macular Degeneration Treatment Market Attractiveness Analysis by Country, 2022–2032
  • Figure 169 : India Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 170 : Global Vs. India Growth Comparison
  • Figure 171 : India Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 172 : India Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 173 : India Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 174 : India Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 175 : Indonesia Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 176 : Global Vs. Indonesia Growth Comparison
  • Figure 177 : Indonesia Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 178 : Indonesia Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 179 : Indonesia Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 180 : Indonesia Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 181 : Malaysia Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 182 : Global Vs. Malaysia Growth Comparison
  • Figure 183 : Malaysia Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 184 : Malaysia Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 185 : Malaysia Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 186 : Malaysia Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 187 : Thailand Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 188 : Global Vs. Thailand Growth Comparison
  • Figure 189 : Thailand Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 190 : Thailand Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 191 : Thailand Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 192 : Thailand Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 193 : Oceania Macular Degeneration Treatment Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 194 : Oceania Macular Degeneration Treatment Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 195 : Oceania Macular Degeneration Treatment Market Value Share, by Drug (2022 E)
  • Figure 196 : Oceania Macular Degeneration Treatment Market Value Share, by Route of administration (2022 E)
  • Figure 197 : Oceania Macular Degeneration Treatment Market Value Share, by Indication (2022 E)
  • Figure 198 : Oceania Macular Degeneration Treatment Market Value Share, by End User (2022 E)
  • Figure 199 : Oceania Macular Degeneration Treatment Market Value Share, by Country (2022 E)
  • Figure 200 : Oceania Macular Degeneration Treatment Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 201 : Oceania Macular Degeneration Treatment Market Attractiveness Analysis by Route of administration, 2022–2032
  • Figure 202 : Oceania Macular Degeneration Treatment Market Attractiveness Analysis by Indication, 2022–2032
  • Figure 203 : Oceania Macular Degeneration Treatment Market Attractiveness Analysis by End User, 2022–2032
  • Figure 204 : Oceania Macular Degeneration Treatment Market Attractiveness Analysis by Country, 2022–2032
  • Figure 205 : Australia Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 206 : Global Vs. Australia Growth Comparison
  • Figure 207 : Australia Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 208 : Australia Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 209 : Australia Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 210 : Australia Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 211 : New Zealand Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 212 : Global Vs New Zealand Growth Comparison
  • Figure 213 : New Zealand Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 214 : New Zealand Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 215 : New Zealand Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 216 : New Zealand Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 217 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Analysis, 2012–2021
  • Figure 218 : Middle East & Africa Macular Degeneration Treatment Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 219 : Middle East & Africa Macular Degeneration Treatment Market Value Share, by Drug (2022 E)
  • Figure 220 : Middle East & Africa Macular Degeneration Treatment Market Value Share, by Route of administration (2022 E)
  • Figure 221 : Middle East & Africa Macular Degeneration Treatment Market Value Share, by Indication (2022 E)
  • Figure 222 : Middle East & Africa Macular Degeneration Treatment Market Value Share, by End User (2022 E)
  • Figure 223 : Middle East & Africa Macular Degeneration Treatment Market Value Share, by Country (2022 E)
  • Figure 224 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis by Drug, 2022–2032
  • Figure 225 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis by Route of administration, 2022–2032
  • Figure 226 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis by Indication, 2022–2032
  • Figure 227 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis by End User, 2022–2032
  • Figure 228 : Middle East & Africa Macular Degeneration Treatment Market Attractiveness Analysis by Country, 2022–2032
  • Figure 229 : GCC Countries Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 230 : Global Vs GCC Countries Growth Comparison
  • Figure 231 : GCC Countries Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 232 : GCC Countries Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 233 : GCC Countries Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 234 : GCC Countries Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 235 : Turkey Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 236 : Global Vs. Turkey Growth Comparison
  • Figure 237 : Turkey Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 238 : Turkey Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 239 : Turkey Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 240 : Turkey Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 241 : South Africa Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 242 : Global Vs. South Africa Growth Comparison
  • Figure 243 : South Africa Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 244 : South Africa Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 245 : South Africa Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 246 : South Africa Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032
  • Figure 247 : North Africa Macular Degeneration Treatment Market Value Proportion Analysis, 2021
  • Figure 248 : Global Vs North Africa Growth Comparison
  • Figure 249 : North Africa Macular Degeneration Treatment Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 250 : North Africa Macular Degeneration Treatment Market Share Analysis (%) by Route of administration, 2021 & 2032
  • Figure 251 : North Africa Macular Degeneration Treatment Market Share Analysis (%) by Indication, 2021 & 2032
  • Figure 252 : North Africa Macular Degeneration Treatment Market Share Analysis (%) by End User, 2021 & 2032

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Persistence Market Research
Price: $4900

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS